ISSAQUAH, Wash.--(BUSINESS WIRE)--BaroPace Inc. announces its Phase I first-in-human trial of PressurePace TM, its patent-pending pacemaker control algorithm for the treatment of heart failure with ...
Please provide your email address to receive an email when new articles are posted on . A new expert consensus decision pathway stresses proper diagnosis and treatment of HF with preserved ejection ...
Heart failure with preserved ejection fraction (HFpEF) can prove a complex problem for clinicians — its prevalence is increasing, it mimics many other conditions, and it can have a devastating impact ...
Phenotyping in HFpEF aids in tailoring therapies, addressing comorbidities, and improving patient outcomes. Artificial intelligence models effectively diagnose HFpEF and predict mortality, enhancing ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Jennifer E. Ho, MD ...
A key opinion leader provides insight into key HFpEF treatment strategies. This is a video synopsis/summary of a panel discussion involving Robert Groves, MD; Eugene E. Wright Jr, MD; Nancy Albert, ...
Please provide your email address to receive an email when new articles are posted on . Tirzepatide reduced outcomes and symptoms for patients with HFpEF and obesity vs. placebo. The safety profile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback